Prescription Advisory Featured News

Prescription Advisory Featured News

How Bad is the Opioid Epidemic? – PBS

Twelve states have more opioid prescriptions than people Not every state has seen an equal rise in opioid use. In Hawaii, doctors wrote 52 opioid prescriptions for every 100 people in 2012, the least of any state according to a 2014 CDC study. In Alabama, it was...

read more

Alabama pain doctor leaves practice with pending administrative complaint against him – ABC WAAY 31

Dr. Murphy reported to the board that both clinic sites see roughly 100 to 120 patients per day and checks the Prescription Drug Monitoring Program database (PDMP) 20-30 times each day.

However, the board points to information from the database, which is starkly different. During the period between January and April 15, 2015, “PDMP records reflect that Dr. Murphy or his office accessed the PDMP site 190 times on 7,000 patients visits. Thus, with an average of 91 patients per day, the PDMP was checked less than five times per day.”

read more

2016’s Top 5 Advances in Primary Care – MedPage Today

2016's Top 5 Advances in Primary Care Opioid crisis and what to do about it tops list MedPage Today asked specialists in primary care around the country to tell us what they thought were the most important clinical developments in 2016. These were the five most...

read more

DEA Ratchets Down Opioid Production – Pain Management News

DEA Ratchets Down Opioid Production The supply of almost every Schedule II opioid manufactured in the United States will be reduced 25% or more in 2017, as required by the Drug Enforcement Administration (DEA). The new quota will be sufficient to meet the estimated...

read more

Follow Prescription Advisory

An improved PDMP … with accurate and timely data analysis should be regarded as the cornerstone of our collective efforts to address prescription drug abuse.

Department of Public Health

Prescription drug monitoring programs (PDMPs) are now active in most states to assist clinicians in identifying potential controlled drug misuse, diversion, or excessive prescribing. Little is still known about the ways in which they are incorporated into workflow and clinical decision making, what barriers continue to exist, and how clinicians are sharing PDMP results with their patients.

Design
Qualitative data were collected through online focus groups and telephone interviews.

Setting
Clinicians from pain management, emergency and family medicine, psychiatry/behavioral health, rehabilitation medicine, internal medicine and dentistry participated.

Patients
Thirty-five clinicians from nine states participated.

Methods
We conducted two online focus groups and seven telephone interviews. A multidisciplinary team then used a grounded theory approach coupled with an immersion–crystallization strategy for identifying key themes in the resulting transcripts.

Results
Some participants, mainly from pain clinics, reported checking the PDMP with every patient, every time. Others checked only for new patients, for new opioid prescriptions, or for patients for whom they suspected abuse. Participants described varied approaches to sharing PDMP information with patients, including openly discussing potential addiction or safety concerns, avoiding discussion altogether, and approaching discussion confrontationally. Participants described patient anger or denial as a common response and noted the role of patient satisfaction surveys as an influence on prescribing.

Conclusion
Routines for accessing PDMP data and how clinicians respond to it vary widely. As PDMP use becomes more widespread, it will be important to understand what approaches are most effective for identifying and addressing unsafe medication use.

Pain Medicine, Volume 15, Issue 7, July 2014 
Share This
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.